Patents by Inventor Sonia H. Yoo

Sonia H. Yoo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Indices for management of dry eye syndrome, corneal ectasia, keratoplasty graft rejection and failure and Fuchs' dystrophy
    Patent number: 8992023
    Abstract: Improved indices for the diagnosis and evaluation of conditions affecting the eye. Specifically, the indices include an Enhanced Epithelial Irregularity Factor (eEIF) for the diagnosis and evaluation of conditions such as dry eye syndrome (DES), Bowman's Ectasia Index (BEI), including enhanced BEI (eBEI) and BEI-Max, and Bowman's Relative Thinning (BRT) Index for the diagnosis and evaluation of ectatic conditions such as keratoconus, pellucid marginal degeneration, post-refractive surgery ectasia, and keratoglobus, and Descemet's Membrane Thickening Index (DMT), Descemet's Rejection Index (DRI), and Descemet's Membrane Irregularity Factor (DIF) for the diagnosis and evaluation of conditions such as keratoplasty rejection and failure and Fuchs' dystrophy.
    Type: Grant
    Filed: April 8, 2014
    Date of Patent: March 31, 2015
    Assignee: University of Miami
    Inventors: Victor L. Perez, Sonia H. Yoo, Jianhua Wang, Mohamed Abou Shousha, Rodrigo Hoffmann
  • INDICES FOR MANAGEMENT OF DRY EYE SYNDROME, CORNEAL ECTASIA, KERATOPLASTY GRAFT REJECTION AND FAILURE AND FUCHS' DYSTROPHY
    Publication number: 20140300862
    Abstract: Improved indices for the diagnosis and evaluation of conditions affecting the eye. Specifically, the indices include an Enhanced Epithelial Irregularity Factor (eEIF) for the diagnosis and evaluation of conditions such as dry eye syndrome (DES), Bowman's Ectasia Index (BEI), including enhanced BEI (eBEI) and BEI-Max, and Bowman's Relative Thinning (BRT) Index for the diagnosis and evaluation of ectatic conditions such as keratoconus, pellucid marginal degeneration, post-refractive surgery ectasia, and keratoglobus, and Descemet's Membrane Thickening Index (DMT), Descemet's Rejection Index (DRI), and Descemet's Membrane Irregularity Factor (DIF) for the diagnosis and evaluation of conditions such as keratoplasty rejection and failure and Fuchs' dystrophy.
    Type: Application
    Filed: April 8, 2014
    Publication date: October 9, 2014
    Inventors: Victor L. Perez, Sonia H. Yoo, Jianhua Wang, Mohamed Abou Shousha, Rodrigo Hoffmann